PFPT
CSTL icon

Pinnacle Financial Partners (Tennessee)’s Castle Biosciences CSTL Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,000
Closed -$257K – 457
2020
Q3 		$257K Buy
+5,000
New +$222K 0.01% 305

Other funds holding CSTL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s CSTL Position: Q4 2020 in Review

Pinnacle Financial Partners (Tennessee) sold out of Castle Biosciences (CSTL) in Q4 2020, closing a stake of 5,000 shares — an estimated $257K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in CSTL in Q3 2020 and held it in 1 quarter. The position peaked at $257K in Q3 2020. 163 funds tracked by Wall St. Rank hold CSTL as of Q4 2020.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Castle Biosciences position as of Q4 2020 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 5,000 Castle Biosciences shares in Q4 2020, an estimated $257K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Castle Biosciences in Q3 2020 and held it in 1 quarter.
  • Pinnacle Financial Partners (Tennessee)'s Castle Biosciences position peaked at $257K in Q3 2020.
  • 163 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2020.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q4 2020, filed 13 Jan 2021.